Amphastar Pharmaceuticals, Inc. (AMPH): Price and Financial Metrics

AMPH POWR Grades

• Growth is the dimension where AMPH ranks best; there it ranks ahead of 93.76% of US stocks.
• AMPH's strongest trending metric is Stability; it's been moving down over the last 179 days.
• AMPH ranks lowest in Momentum; there it ranks in the 8th percentile.

AMPH Stock Summary

• AMPH's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1.89 -- higher than just 8.58% of US-listed equities with positive expected earnings growth.
• With a year-over-year growth in debt of 55.59%, Amphastar Pharmaceuticals Inc's debt growth rate surpasses 84.69% of about US stocks.
• Over the past twelve months, AMPH has reported earnings growth of 1,472.9%, putting it ahead of 98.51% of US stocks in our set.
• Stocks that are quantitatively similar to AMPH, based on their financial statements, market capitalization, and price volatility, are AOSL, SMTC, FORM, KOPN, and PSNL.
• AMPH's SEC filings can be seen here. And to visit Amphastar Pharmaceuticals Inc's official web site, go to www.amphastar.com.

AMPH Valuation Summary

• AMPH's EV/EBIT ratio is 46.7; this is 59.39% higher than that of the median Healthcare stock.
• AMPH's EV/EBIT ratio has moved up 19.7 over the prior 87 months.
• Over the past 87 months, AMPH's price/sales ratio has gone up 0.8.

Below are key valuation metrics over time for AMPH.

AMPH Growth Metrics

Its 5 year net cashflow from operations growth rate is now at 101.3%.
• Its year over year revenue growth rate is now at 12.5%.
• The year over year cash and equivalents growth rate now stands at 79.57%.

AMPH's revenue has moved up $194,452,000 over the prior 52 months.

The table below shows AMPH's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	437.768	97.994	62.116
2021-09-30	412.802	74.446	36.083
2021-06-30	384.035	80.684	10.454
2021-03-31	368.178	78.614	2.495
2020-12-31	349.846	57.266	1.403
2020-09-30	337.308	46.025	6.65

AMPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AMPH has a Quality Grade of C, ranking ahead of 66.19% of graded US stocks.
• AMPH's asset turnover comes in at 0.601 -- ranking 59th of 680 Pharmaceutical Products stocks.
• VTVT, MTEX, and BBI are the stocks whose asset turnover ratios are most correlated with AMPH.

The table below shows AMPH's key quality metrics over time.